Moderna & Merck Announce Promising Results From mRNA Cancer Vaccine For Melanoma

← All Community

Moderna & Merck Announce Promising Results From mRNA Cancer Vaccine For Melanoma

Ask an Expert

For the first time ever reported in a phase three trial, we are seeing promising results for a personalized mRNA vaccine treatment from Moderna and Merck in melanoma patients treating remaining cells after surgery to remove the primary site.

The views in this piece are those of its author or guests and do not necessarily reflect those of The Cancer Project. This is not medical advice. Talk with your care team about your own care.

Share this

Keep Exploring

Ask an Expert

Can A Sunburn Cause Skin Cancer?

Ask an Expert

Cancer Recurrence: What We Know About Dormant Cancer Cells And How They Can Cause Recurrence

Ask an Expert

What Is Rectal Spacing And Why Is It Recommended For Radiation Prostate Cancer Treatment?

Join us at The Cancer Project

Get weekly stories, research updates, and ways to get involved.

The Cancer Project

Real stories, trusted information, and a community that gets it, so no one faces cancer alone.

Get in Touch

Have a question, an idea, or a story to share? We would love to hear from you.

Send us a messageShare your story →
© 2026 The Cancer Project

This website does not provide medical advice. Content on The Cancer Project is for general information only and is not a substitute for professional diagnosis or treatment. Always talk with your doctor or care team about your health. Not all content is controlled by The Cancer Project or represents its views. Stories, research, and perspectives also come from patients, caregivers, podcast guests, and outside organizations.

Privacy PolicyMedical Disclaimer